Home
Resources
Publications
Acute, Subchronic and Chronic Toxicity of the New Angiotensin Converting Enzyme Inhibitor Ramipril

Acute, Subchronic and Chronic Toxicity of the New Angiotensin Converting Enzyme Inhibitor Ramipril

H H Donaubauer, D Mayer

Arzneimittelforschung. 1988 Jan;38(1):14-20.

PMID: 2966628

Abstract:

Acute, subchronic and chronic toxicity studies of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S, 3S, 5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (ramipril, Hoe 498) were conducted in mice, rats, dogs and monkeys. The acute toxicity in mice, rats, and dogs after oral and intravenous administration is very low. There were no significant differences in LD50 values between male and female animals. Treatment periods up to 6 months in rats and monkeys and up to 12 months in dogs revealed consistent compound-related effects with respect to the kidneys and the hemopoietic system probably due to exaggerated pharmacological activity. Species-specific lesions in the gastric fundal mucosa were noted exclusively in rats. No adverse effects were seen at doses of 0.25 mg/kg/d in rats, 2.5 mg/kg/d in dogs, and 0.5 mg/kg/d in monkeys. It is concluded that ramipril can be safely used in humans.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP108313117	Ramipril Related Compound A		108313-11-7	Price
AP108731959	Ramipril Related Compound D		108731-95-9	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: